Phase III trial of cannabidiol (Epidiolex) in paediatric patients with tuberous sclerosis complex

Trial Profile

Phase III trial of cannabidiol (Epidiolex) in paediatric patients with tuberous sclerosis complex

Planning
Phase of Trial: Phase III

Latest Information Update: 29 Apr 2015

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Tuberous sclerosis
  • Focus Therapeutic Use
  • Sponsors GW Pharmaceuticals
  • Most Recent Events

    • 29 Apr 2015 New trial record
    • 27 Apr 2015 This trial is expected to be initiated in 2015, according to a GW Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top